A randomized, double-blind, placebo-controlled, phase III study of the short-acting β1-adrenergic receptor blocker Landiolol hydrochloride for coronary computed tomography angiography in Japanese patients with suspected ischemic cardiac disease

Masaharu Hirano, Akira Yamashina, Kazuhiro Hara, Yuji Ikari, Masahiro Jinzaki, Misako Iino, Takuhiro Yamaguchi, Mitsunobu Tanimoto, Sachio Kuribayashi

研究成果: Article

5 引用 (Scopus)

フィンガープリント A randomized, double-blind, placebo-controlled, phase III study of the short-acting β<sub>1</sub>-adrenergic receptor blocker Landiolol hydrochloride for coronary computed tomography angiography in Japanese patients with suspected ischemic cardiac disease' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

Medicine & Life Sciences